Edition:
United Kingdom

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

9.99USD
18 Apr 2019
Change (% chg)

$-0.13 (-1.28%)
Prev Close
$10.12
Open
$10.14
Day's High
$10.20
Day's Low
$9.77
Volume
144,903
Avg. Vol
172,564
52-wk High
$27.80
52-wk Low
$9.38

About

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeutics against difficult-to-drug targets. Its pipeline is focused on the development... (more)

Overall

Beta: 0.64
Market Cap(Mil.): $458.04
Shares Outstanding(Mil.): 45.26
Dividend: --
Yield (%): --

Financials

  CTMX.OQ Industry Sector
P/E (TTM): -- 106.23 59.19
EPS (TTM): -1.99 -- --
ROI: -24.32 7.96 11.77
ROE: -84.28 8.09 12.61

Earnings vs. Estimates